The predicament arising from the coronavirus disease 2019 (COVID-19) pandemic has
become one of the most significant modern public health challenges. Despite uncertainties …

The pandemic of the new coronavirus, known as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has urged the nations to an unprecedented world-wide …

Coronavirus disease 2019 (COVID-19), which is caused by a novel severe acute respiratory
syndrome coronavirus (SARS-CoV-2), has recently emerged as a global health threat. To …

Introduction Hydroxycloroquine (HCQ) has been extensively studied for treatment and
prevention of coronavirus diseases 2019 (COVID‐19) from the start of the pandemic …

Background On the 11 March 2020, the World Health Organization (WHO) declared that
COVID-19 was a pandemic. To date, there are no medical treatments for COVID-19 with …

After the global pandemic of the new coronavirus, its rapid spread and many victims, it is
necessary to find an effective vaccine or drugs to overcome it. Most specialists consider that …

Objectives The emergence of SARS‐CoV‐2 has presented clinicians with a difficult
therapeutic dilemma. With supportive care as the current mainstay of treatment, the fatality …

In December 2019, a severe outbreak of a novel coronavirus (COVID-19) occurred in the
whole world, posing a great threat to people's health. With the outbreak and development of …

CONTEXT: Based on the results of preliminary studies, the off-label use of
hydroxychloroquine for COVID-19 infection has been observed in practice. OBJECTIVES: To …

Background During the initial phases of the coronavirus disease 2019 (COVID-19)
epidemic, there was an unfounded fervor surrounding the use of hydroxychloroquine (HCQ); …